Pharmacy-level barriers to opioid overdose prevention: availability and accessibility of naloxone and buprenorphine–naloxone in high-risk Texas counties
Darouiche, K. G., Malik, M. M., Mohr, M. T., Hagenimana, M. A., Digbeu, B. D. E., Cunningham, K. A., Farr, N. M. & Dostal, C. R., Dec 2026, In: Harm Reduction Journal. 23, 1, 86.Research output: Contribution to journal › Article › peer-review
